We are live on
!
Find out more
MCP
Maso Capital Partners Portfolio holdings
AUM
$60.9M
1-Year Est. Return
0.32%
This Fund
S&P 500
This Quarter
Est. Return
+4.96%
1 Year Est. Return
-0.32%
3 Year Est. Return
+8.67%
5 Year Est. Return
-6.95%
10 Year Est. Return
–
AUM
$311M
AUM Growth
+$32.6M
(+12%)
Cap. Flow
+$5.72M
Cap. Flow
% of AUM
1.84%
Top 10 Holdings %
Top 10 Hldgs %
92.57%
Holding
24
New
5
Increased
10
Reduced
2
Closed
4
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CBPO
China Biologic Products Holdings, Inc.
CBPO
|
+$36.6M |
| 2 |
AGN
Allergan plc
AGN
|
+$34.2M |
| 3 |
BITA
Bitauto Holdings Limited
BITA
|
+$22.7M |
| 4 |
ZAYO
Zayo Group Holdings, Inc.
ZAYO
|
+$22.1M |
| 5 |
CYOU
Changyou.com Limited American Depositary Share
CYOU
|
+$13.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$89.3M |
| 2 |
BPL
Buckeye Partners, L.P.
BPL
|
+$30.8M |
| 3 |
GWR
Genesee & Wyoming Inc.
GWR
|
+$12.1M |
| 4 |
Beyond Meat
BYND
|
+$1.46M |
| 5 |
Alibaba
BABA
|
+$943K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 25.52% |
| 2 | Financials | 7.34% |
| 3 | Consumer Staples | 3.65% |
| 4 | Consumer Discretionary | 3.53% |
| 5 | Communication Services | 1.38% |
Similar funds
GVIC
MA
ITVII
MIG
LAM
NCFG
KA
SGA
Maso Capital Partners's Q4 2019 Portfolio in Review
As of Q4 2019, Maso Capital Partners held 24 positions worth $311M, up 12% from $278M the previous quarter. Its ten largest holdings account for 93% of the portfolio.
Maso Capital Partners's Q4 2019 filing shows 5 new, 10 increased, 2 reduced and 4 closed positions. Its largest new stake was Zayo Group Holdings, Inc.: 646,318 shares worth $22.4M. The largest sale was Celgene Corp, an estimated $89.3M.
By sector, the portfolio is most concentrated in Healthcare at 26% of assets, down from 45% a quarter earlier, followed by Financials and Consumer Staples.
- Maso Capital Partners's largest Q4 2019 buy was Zayo Group Holdings, Inc.: 646,318 shares worth $22.4M.
- Maso Capital Partners added most to China Biologic Products Holdings, Inc. in Q4 2019, an estimated $36.6M increase.
- Maso Capital Partners's biggest Q4 2019 reduction was Alibaba, cutting an estimated $943K.
- Maso Capital Partners fully exited Celgene Corp in Q4 2019, selling an estimated $89.3M.
- Maso Capital Partners's ten largest holdings make up 93% of its $311M portfolio in Q4 2019.
- Maso Capital Partners opened 5 new positions and closed 4 in Q4 2019.
- Maso Capital Partners's portfolio value rose 12% quarter-over-quarter to $311M.
Based on Maso Capital Partners's 13F filing for Q4 2019, filed 12 Feb 2020.